Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories ( For more information about these ontologies, see the MGI Publications Page at

Term:increased sarcoma incidence
go back to main search page
Accession:MP:0002032 term browser browse the term
Definition:greater than the expected number of a connective tissue neoplasm associated with the proliferation of embryonically-derived mesodermal cells, occurring in a specific population in a given time period
Synonyms:related_synonym: sarcoma

show annotations for term's descendants           Sort by:
increased osteosarcoma incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 IAGP DNA:deletion RGD PMID:19825367 RGD:5147850 NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 4990
    neoplasm 229
      altered tumor susceptibility 222
        abnormal tumor incidence 211
          abnormal classified tumor incidence 101
            increased classified tumor incidence 101
              increased malignant tumor incidence 60
                increased sarcoma incidence 2
                  increased fibrosarcoma incidence + 0
                  increased hemangiosarcoma incidence + 1
                  increased histiocytic sarcoma incidence 0
                  increased leiomyosarcoma incidence 0
                  increased liposarcoma incidence 0
                  increased myeloid sarcoma incidence 0
                  increased odontosarcoma incidence 0
                  increased osteosarcoma incidence 1
                  increased rhabdomyosarcoma incidence 1
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.